Metabolic disorders and the risk of cholangiocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metabolic disorders and the risk of cholangiocarcinoma

Published:2021-08-21 Issue:9 Volume:15 Page:999-1007
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Ghidini Michele¹,Ramai Daryl²,Facciorusso Antonio³^ORCID,Singh Jameel⁴,Tai Waqqas²,Rijavec Erika¹,Galassi Barbara¹,Grossi Francesco⁵,Indini Alice¹

Affiliation:

1. Medical Oncology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

2. Department of Internal Medicine, The Brooklyn Hospital Center, Brooklyn, New York, USA

3. Section of Gastroenterology, Department of Medical Sciences, University of Foggia, Foggia, Italy

4. Department of Internal Medicine, Mather Hospital, Northwell Health, Port Jefferson, New York, USA

5. Department of Medicine and Surgery, Medical Oncology Unit, ASST Sette Laghi, Varese, Italy

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2021.1946393

Reference101 articles.

1. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

2. Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma

3. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update

4. Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas

5. Risk factors for cholangiocarcinoma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival and Cardiovascular Disease Mortality among Primary Liver Cancer Patients: A Population-based Study;Heliyon;2024-09

2. Integrative analysis of serum-derived exosomal lncRNA profiles of alveolar echinococcosis patients;Gene;2024-01

3. Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies;Gut;2023-11-24

4. The influence of obesity on the risk of development of selected gastrointestinal cancers;Humanities & Social Sciences Reviews;2023-08-16

5. Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications;International Journal of Molecular Sciences;2023-07-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3